Peroxiredoxins
"Peroxiredoxins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of ubiquitously-expressed peroxidases that play a role in the reduction of a broad spectrum of PEROXIDES like HYDROGEN PEROXIDE; LIPID PEROXIDES and peroxinitrite. They are found in a wide range of organisms, such as BACTERIA; PLANTS; and MAMMALS. The enzyme requires the presence of a thiol-containing intermediate such as THIOREDOXIN as a reducing cofactor.
Descriptor ID |
D054464
|
MeSH Number(s) |
D08.811.682.732.850
|
Concept/Terms |
Peroxiredoxins- Peroxiredoxins
- Alkylhydroperoxide Reductase
- Peroxidoxin
- Thioredoxin Peroxidase
- Protector Protein (Mixed-Function Oxidase Systems)
- Thiol-Specific Antioxidant Protein
- Thiol Specific Antioxidant Protein
- Alkyl Hydroperoxide Reductase
- Hydroperoxide Reductase, Alkyl
- Peroxiredoxin
Peroxiredoxin II- Peroxiredoxin II
- Thioredoxin Peroxidase 1
- Thioredoxin-Dependent Peroxide Reductase 1
- Thioredoxin Dependent Peroxide Reductase 1
- Peroxiredoxin 2
Peroxiredoxin I- Peroxiredoxin I
- Thioredoxin Peroxidase 2
- Thioredoxin-Dependent Peroxide Reductase 2
- Thioredoxin Dependent Peroxide Reductase 2
- Peroxiredoxin 1
|
Below are MeSH descriptors whose meaning is more general than "Peroxiredoxins".
Below are MeSH descriptors whose meaning is more specific than "Peroxiredoxins".
This graph shows the total number of publications written about "Peroxiredoxins" by people in this website by year, and whether "Peroxiredoxins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 2 | 2 | 2006 | 0 | 1 | 1 | 2008 | 1 | 0 | 1 | 2010 | 1 | 0 | 1 | 2011 | 1 | 2 | 3 | 2012 | 1 | 1 | 2 | 2013 | 2 | 0 | 2 | 2015 | 0 | 1 | 1 | 2018 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Peroxiredoxins" by people in Profiles.
-
Bolduc JA, Nelson KJ, Haynes AC, Lee J, Reisz JA, Graff AH, Clodfelter JE, Parsonage D, Poole LB, Furdui CM, Lowther WT. Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxins. J Biol Chem. 2018 07 27; 293(30):11901-11912.
-
Petersen DR, Orlicky DJ, Roede JR, Shearn CT. Aberrant expression of redox regulatory proteins in patients with concomitant primary Sclerosing cholangitis/inflammatory bowel disease. Exp Mol Pathol. 2018 08; 105(1):32-36.
-
Guo F, He H, Fu ZC, Huang S, Chen T, Papasian CJ, Morse LR, Xu Y, Battaglino RA, Yang XF, Jiang Z, Xin HB, Fu M. Adipocyte-derived PAMM suppresses macrophage inflammation by inhibiting MAPK signalling. Biochem J. 2015 Dec 15; 472(3):309-18.
-
Xu Y, Morse LR, da Silva RAB, Wang D, Battaglino RA. A short report: PAMM, a novel antioxidant protein, induced by oxidative stress. Redox Biol. 2015 Dec; 6:446-453.
-
Harris PS, Roy SR, Coughlan C, Orlicky DJ, Liang Y, Shearn CT, Roede JR, Fritz KS. Chronic ethanol consumption induces mitochondrial protein acetylation and oxidative stress in the kidney. Redox Biol. 2015 Dec; 6:33-40.
-
Haynes AC, Qian J, Reisz JA, Furdui CM, Lowther WT. Molecular basis for the resistance of human mitochondrial 2-Cys peroxiredoxin 3 to hyperoxidation. J Biol Chem. 2013 Oct 11; 288(41):29714-23.
-
Hossain GS, Lynn EG, Maclean KN, Zhou J, Dickhout JG, Lhot?k S, Trigatti B, Capone J, Rho J, Tang D, McCulloch CA, Al-Bondokji I, Malloy MJ, Pullinger CR, Kane JP, Li Y, Shiffman D, Austin RC. Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expression. J Am Heart Assoc. 2013 May 17; 2(3):e000134.
-
Lopert P, Day BJ, Patel M. Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells. PLoS One. 2012; 7(11):e50683.
-
Marrocco C, Pallotta V, D'alessandro A, Alves G, Zolla L. Red blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping. Blood Transfus. 2012 May; 10 Suppl 2:s71-7.
-
Kunde SS, Roede JR, Vos MB, Orr ML, Go YM, Park Y, Ziegler TR, Jones DP. Hepatic oxidative stress in fructose-induced fatty liver is not caused by sulfur amino acid insufficiency. Nutrients. 2011 11; 3(11):987-1002.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|